The ability of secreted Transforming Growth Factor  (TGF) proteins to act as morphogens dictates that their influence be strictly regulated. Here, we report that maternally contributed fat facets (faf; a homolog of USP9X/FAM) is essential for proper interpretation of the zygotic Decapentaplegic (Dpp) morphogen gradient that patterns the embryonic dorsal-ventral axis. The data suggest that the loss of faf reduces the activity of Medea (a homolog of Smad4) below the minimum necessary for adequate Dpp signaling and that this is likely due to excessive ubiquitylation on a specific lysine. This study supports the hypothesis that the control of cellular responsiveness to TGF signals at the level of Smad4 ubiquitylation is a conserved mechanism required for proper implementation of a morphogen gradient.
INTRODUCTION
TGF signals are pleiotropic regulators of animal development. In Drosophila, the TGF family member Dpp, a homolog of vertebrate BMP2/4, initiates signal transduction with a complex of receptor kinases. One of the receptors then phosphorylates Mad, a member of the Smad family of TGF signal transducers. Once phosphorylated, Mad translocates to the nucleus, forms a complex with its sister Smad protein Medea (Med) and regulates gene expression in cooperation with tissue-specific co-factors (Derynck and Miyazono, 2008) .
During early embryogenesis, Dpp plays a key role in orchestrating dorsal-ventral (DV) axis formation. Prior to dpp zygotic transcription, maternally contributed Mad and Med are present in every cell. At cellular blastoderm stage, a dorsal to ventral extracellular gradient of Dpp protein is generated via a system of extracellular regulation that is translated quantitatively by each cell into intracellular levels of phosphorylated Mad (pMad). At specific thresholds of Mad phosphorylation, cells implement distinct developmental programs. Perturbation of the Dpp gradient (dpp mutations) or its interpretation (Mad or Med mutations) results in aberrant cell fate decisions and abnormal development (Shimmi et al., 2005) .
Recent evidence indicates that Med (a homolog of vertebrate Smad4) is also a tunable determinant of cellular responses to TGF signals. In vertebrate embryos, Smad4 monoubiquitylation opposes the formation of Smad complexes, providing a mechanism by which nuclei monitor the presence of extracellular ligands and activate gene expression appropriately. In Xenopus, knockdown of the Smad4 ubiquitin ligase Ectodermin (Ecto/TRIM33/Tif1-) causes expansion of mesoderm markers, whereas knockdown of the Smad4 deubiquitylase USP9X/FAM causes defective mesoderm induction (Dupont et al., 2005; Dupont et al., 2009) . In mouse embryos, epiblast-specific Ecto (Trim33 -Mouse Genome Informatics) knockout leads to upregulation of Nodal-dependent mesoderm-induction (Morsut et al., 2010) . At present it is unclear whether this mechanism for Smad4 regulation is truly general or vertebrate specific.
The Smad4 deubiquitylase USP9X/FAM is homologous to Drosophila fat-facets (faf), suggesting conservation of Smad4/Med regulation by deubiquitylation (supplementary material Fig. S1 ) . This hypothesis is supported by studies in Drosophila where expression of Xenopus Ecto led to phenotypes similar to mutations in Med that were rescued by co-expression of Drosophila Faf (Dupont et al., 2009 ). In addition, sequence analysis (Konikoff et al., 2008) found that a conserved lysine (Lys 519 in human Smad4; Lys 738 in Med) is the residue through which Ecto and USP9X regulate Smad4 activity (Dupont et al., 2009) . To date, no developmental roles for Faf in TGF signaling have been identified via mutational analyses in any species.
Here, we report the maternal and zygotic requirement for faf in Dpp signaling during DV patterning. We analyzed faf transheterozygous genotypes that generate embryos capable of surviving beyond the faf-null phenotype of blastoderm arrest. We found that a subset of these are dominant maternal enhancers of dpp mutations that engender defects in DV axis formation. We were able to rescue faf enhancement of dpp with a nonubiquitylatable form of Med. Taken together, the data suggest an important developmental role for Faf as a Med deubiquitylase during Dpp DV signaling. Overall, our study reveals that deubiquitylation is a highly conserved mechanism employed by cells to fine-tune their interpretation of TGF signals.
MATERIALS AND METHODS

Fly stocks
Mutant strains are: faf BP , faf F08 , faf B3 , faf BX3 , faf B4 , faf B5 , faf B6 (Fischer-Vize et al., 1992) , faf EP381 (Berger et al., 2001) , dpp hr4 , dpp hr27 , dpp Hin61 (St Johnston et al., 1990) , sog y506 (Ferguson and Anderson, 1992) , Med 8 (Wisotzkey et al., 1998) , Med 15 , Med 17 (Hudson et al., 1998) and Mad
12
(e.g. Sekelsky et al., 1995) . Transgenic strains are: nos.Gal4:VP16-MVD1 (van Doren et al., 1998) , UASp.GFP-Tub84B (Grieder et al., 2000) and act-lacZ-CB1 (Bourgouin et al., 1992) .
Genetics
Assays of dominant maternal enhancement, zygotic lethality, maternal effect lethality, synthetic lethality and transgenic rescue of faf enhancement were conducted using standard methods (Sekelsky et al., 1995) . Stage of lethality tests were as described (Takaesu et al., 2006) . Alignments and phylogenetic trees were as described previously (Konikoff et al., 2010) .
Cuticles and embryos
Cuticle scoring followed Wharton et al. (Wharton et al., 1993) . Nonfluorescent antibody labeling followed Johnson et al. (Johnson et al., 2007) . Double labeling employed anti-lacZ (Organon Teknika) and anti-Hnt (DSHB-1G9) detected with biotinylated goat anti-mouse or anti-rabbit and Vecta Stain Elite (Vector Labs). RNA in situ double labeling of embryos with rho or dpp or sog and lacZ cDNAs or antibody double labeling with anti-pMad and anti-lacZ were as described previously (Takaesu et al., 2002; Shimmi et al., 2005) . Fluorescence double labeling of embryos followed methods of Quijano et al. (Quijano et al., 2010) using anti-Hnt and anti-lacZ. Additional antibodies employed in unfertilized eggs and embryos were anti-Flag (Sigma) and anti-Bonus (Beckstead et al., 2001) . Secondary antibodies were Alexa Fluor goat anti-rabbit, anti-mouse and anti-guinea pig (Molecular Probes).
Transgenes
A Med-K738R cDNA was generated by site directed mutagenesis from Med-wt in pAcpA (McCabe et al., 2004) . These were subcloned as MluINheI fragments into a modified pUASP vector (Rørth, 1998 ) with a novel multiple cloning site. Human Smad4-K519R and Smad4-wt cDNAs in pRK5 (Dupont et al., 2009) were excised with EcoRI-SalI and subcloned as EcoRI-PmeI fragments into the modified pUASP vector. All UASP plasmids were verified by sequencing prior to generating multiple transgenic lines by standard methods.
RESULTS
Given that USP9X deubiquitylates Smad4, we tested the hypothesis that faf, the fly USP9X homolog, plays a role in Dpp signal transduction, a process in which Med is a major component. Two events that depend on Dpp signaling are adult wing vein formation and DV patterning in the early embryo. A study of wings from adults generated by a set of inter se crosses between eight faf alleles did not identify any defects. We did note that transheterozygous faf mutant females are sterile, as reported by Fischer-Vize et al. (Fischer-Vize et al., 1992) . This prompted us to examine the possibility that faf plays a role in Dpp signaling during embryonic DV patterning.
faf mutations are dominant maternal enhancers of dpp mutations We began with the classic assay for dominant maternal enhancement of dpp recessive lethal mutations that led to the discovery of Mad and Med (Sekelsky et al., 1995; Raftery et al., 1995) . Missense mutations in the Dpp pro-domain (dpp hr4 ; G402E) (Wharton et al., 1996) impact ligand cleavage, dimerization or stability and are almost completely recessive; they survive at near wild-type levels when heterozygous but are absolutely lethal when homozygous. In this assay, a female parent with a heterozygous mutation at a second locus reduces the survival of the dpp recessive allele as a heterozygote from near wild type to near absolute lethality. For Mad and Med, the explanation is that the reduction in the dose of functional maternal RNA for either of these signal transducers in combination with a reduction in the dose of fully functional Dpp leads to a diminished Dpp morphogen gradient, ventralization of the embryo and death.
Employing females heterozygous for seven of our eight faf alleles (faf EP381 is a P insertion in the first intron creating a viable allele that was tested as a homozygote), we found that faf Table S2 ). These results are consistent with data for both Mad and Med (Sekelsky et al., 1995; Raftery et al., 1995) . We then analyzed cuticles from the two faf maternal enhancement crosses and compared them with dpp hr4 homozygous and Med enhanced dpp hr4 cuticles. The analysis revealed that faf enhanced dpp hr4 progeny displayed defects in DV patterning similar to those of ventralized dpp hr4 homozygous and Med enhanced dpp hr4 progeny ( Fig. 1A-D ; supplementary material Table  S3A ). Shared defects include a herniated head skeleton at the anterior, misshapen and/or internalized Filzkorper at the posterior, dorsal extension of the ventral denticle belts and a partially Ushaped body. These similarity of faf enhanced dpp hr4 embryos to dpp hr4 homozygotes and Med enhanced dpp hr4 embryos suggest that maternal Faf deubiquitylation is important for Dpp signaling during DV patterning.
faf zygotic mutants display DV defects
The maternal enhancement experiments showed that faf mutations can sensitize embryonic development to defective Dpp signaling. Therefore, we sought to determine whether faf mutations alone can cause defects comparable with mutations in the Dpp pathway. In these studies, we analyzed both transheterozygous zygotic and maternal mutants by assessing survival and cuticle phenotypes. We employed an inter se strategy with eight faf mutant alleles to generate faf transheterozygous zygotic mutant progeny (e.g. faf
F08
/faf B3 ). We found that many faf zygotic mutant combinations are fully viable but others generate adults at less than 50% of the expected ratio. In three genotypes, only 25% of the expected faf mutants survived to adulthood ( Fig. 1J ; supplementary material Table S1B). A reduction in faf zygotic mutant survival had not been noted before.
In cuticle studies of genotypes with reduced survival, we observed that faf transheterozygous zygotic mutants displayed a range of defects in DV patterning ( Fig. 1F-I ; supplementary material Table S3B ). The most severely affected faf zygotic mutants (faf
/faf
B3
, 27% of expected) displayed DV defects that resembled dpp null genotypes. Other faf zygotic mutants generated cuticles similar to dpp hr4 homozygous and dpp hr4 enhanced cuticles. This data suggests that, in addition to the maternal requirement identified in enhancement assays, there is also a zygotic requirement for faf in Dpp signaling during DV patterning.
faf maternal mutants form an allelic series that generates a gradient of DV defects We continued the inter se experiment for a second generation to confirm a maternal requirement for faf in Dpp DV signaling. We employed transheterozygous females bearing all combinations of the eight faf mutants in crosses to wild-type males. The progeny will be heterozygous for a faf mutant allele derived from their
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Development 139 (15) mother and a wild-type faf allele from their father. The paternal wild-type allele allows normal development and defects are attributed to the faf mutation in the maternal parent. Embryos derived from faf homozygous mutant females primarily die prior to the onset of embryonic dpp expression (Fischer-Vize et al., 1992). However, our second-generation crosses revealed that embryos from a subset of faf transheterozygous mutant females survive past this point and that their cuticles display DV defects similar to ventralized dpp mutants. Importantly, cuticles derived from embryos generated by these faf mutant females could be ordered into an allelic series. As opposed to the zygotic requirement for faf in DV patterning, which was revealed by combinations of strong hypomorphic alleles, the graded maternal requirement for faf was identified in combinations of weak hypomorphic alleles ( Fig. 2A-G The faf maternal mutant allelic series creates a gradient of DV defects that parallels the phenotypes of an allelic series constructed for dpp (Wharton et al., 1993) .
faf mutations enhance Med mutations and can partially suppress sog mutations If the mechanism by which USP9X deubiquitylates Smad4 is operating in Dpp DV signaling, then one prediction is that reducing faf and Med dose together in double heterozygous embryos will reduce the amount of functional Med to the point of interfering with Dpp signaling. A corollary is that if the effect of the double heterozygote is non-reciprocal, then the more crucial component is the one that must be compromised in the mother to obtain an effect.
In our analysis, we observed that a subset of faf and Med double heterozygous genotypes displayed the synthetic lethality predicted by the USP9X-Smad4 mechanism. In these cases, fewer than half the expected number of double heterozygous progeny survived ( Fig.  2J ; supplementary material Table S1C ). In all combinations with synthetic lethality, the female parent was heterozygous for Med 8 while the male parent contributed a faf mutant allele, indicating that maternal reduction in Med is more damaging to Dpp DV signaling than maternal reduction in faf. Cuticle studies of double heterozygous genotypes with reduced survival revealed that the lethality was due to defects in DV patterning ( Fig. 2H ,J; supplementary material Table  S3C ). Data prior to this point revealed that faf plays a role in Dpp DV signaling and now faf-Med synthetic lethality suggests a mechanism: faf impacts Dpp DV signaling via interactions with Med. This suggestion is supported by results from crosses of faf mutants and Mad 12 (null allele for Dpp signaling) (Sekelsky et al., 1995) . All Mad and faf double heterozygous genotypes displayed normal survival and wild-type cuticles.
We then examined the ability of faf to suppress dorsalization defects caused by to mutations in sog. If dpp mutations are able to partially suppress sog mutant phenotypes (Francois et al., 1994) , then mutations affecting Dpp DV signaling pathway components will have the same effect. We validated the prediction with a mutation in Med and found that strong faf mutant alleles have the same effect ( Fig. 2K -L; supplementary material Table S3D ). Taken together, our survival assays and cuticle data suggest that maternal and zygotic faf activity plays a positive role in Dpp DV signaling via interactions with Med. the amnioserosa, the dorsal-most embryonic tissue and the one that requires the highest level of Dpp signaling (e.g. Raftery et al., 1995) . Each of the Hin experiments was consistent with cuticle data derived from the same cross (Fig. 3A-G) .
Loss of hindsight and
The dominant maternal enhancement of dpp hr4 by faf F08 led to a loss of Hin-expressing cells, though less severe in this example than Med 17 enhancement of dpp hr4 and homozygosity for dpp hr4 . Zygotic transheterozygous combinations of strong faf mutant alleles also displayed reduced Hin expression. Embryos derived from faf maternal transheterozygous mutants for which a subset survive past the null phenotype exhibit essentially no Hin expression. This closely resembles dpp hr4 homozygous embryos and Med mutant germline clones (Hudson et al., 1998) . Med maternal and faf paternal double heterozygous embryos display reduced Hin expression whereas embryos from the reverse cross (Med paternal and faf maternal) are wild type.
We extended the analysis to rhomboid (rho) expression in the dorsal ectoderm of cellular blastoderm (stage 5) embryos: rho is the earliest known target of Dpp signaling in embryonic DV patterning (Yu et al., 2000) and assay of rho transcription is also a standard means of evaluating Dpp activity (e.g. Ross et al., 2001) . If faf mutations influence dorsal ectoderm rho expression, this would further support a role in Dpp DV signaling (Fig. 3H-N) .
The (Wharton et al., 1993) . faf B4 is an in-frame six-residue insertion at position 279 and faf B5 is a frame-shift after amino acid 2150. These widely spaced alternations each generate a weak hypomorphic allele (Fisher-Vize et al., 1992; Chen and Fisher, 2000) . (C)faf
B4
/faf
B6 cuticle displays increased ventralization with a herniated head, defective Filzkorper and denticle belts that extend throughout the ventral half of the cuticle similar to a dpp hr56 homozygous cuticle. faf B6 is a nonsense mutation at position 459 that functions as an near protein-null allele.
B4 cuticle displays significant ventralization with a herniated head, defective Filzkorper, malformed dorsal cuticle and denticle belts that extend well into the dorsal half of the embryo similar to a dpp hr92 homozygous cuticle and to cuticles from Med mutant germline clones with partial paternal rescue (Hudson et al., 1998 . Embryos derived from faf maternal transheterozygous mutants for which a subset survive past the null phenotype exhibit no rho expression in any region of the dorsal ectoderm, a phenotype also seen in embryos derived from homozygous Med 15 females. Med maternal and faf paternal double heterozygous embryos display reduced rho expression in the central region. Each of the rho experiments was consistent with the cuticle and Hin data derived from the same cross.
We replicated all of these results with a second missense mutation in the prodomain-dpp hr27 (E316K) (Wharton et al., 1996 (Shimmi et al., 2005) . Assays of cuticles or Hin or rho expression in faf mutants cannot formally exclude the possibility that faf modulates DV patterning by regulating dpp and/or sog transcription. We conducted dpp and sog situ hybridization studies using faf maternal mutants for which a subset of embryos survive past the null phenotype and zygotic mutants that display DV defects. Both faf B4 /faf B5 maternal and faf F08 /faf BP zygotic mutant embryos contain wild-type dpp RNA (Fig. 4A-C) as well as wildtype sog RNA (Fig. 4D-F) expression. This suggests that the alternative hypothesis of transcriptional activation is false.
We also analyzed pMad expression in faf maternal and zygotic mutants. This assay can provide evidence that will allow us to further eliminate the possibility that faf influences Dpp DV signaling via interactions with Mad, rather than Med. Both maternal and zygotic faf mutant combinations display normal pMad activation and localization to the dorsal-most region at stage 5 ( Fig. 4G-I ). These pMad results are reproducible in multiple maternal and zygotic faf mutants (supplementary material Fig. S2 ) and are similar to pMad expression in dpp hr4 heterozygous embryos that have wild-type DV patterning (supplementary material Fig. S3 ). These data confirm our hypothesis that faf blocks Dpp DV signaling downstream of Mad. We noted that faf maternal mutants show a slightly broader pMad stripe and believe this is due to reduced Med activity in a Dpp feedback loop (Wang and Ferguson, 2005) .
Taken together, all of the data are consistent with our hypothesis for the role of faf in Dpp signaling: loss of maternal or zygotic faf leads to a reduction in Med activity, insufficient Dpp signal transduction and DV defects. Thus, Faf deubiquitylation of Med during Dpp DV signaling is the first genetically defined RESEARCH ARTICLE Faf deubiquitylation in Dpp signaling developmental event employing the conserved USP9X-Smad4 regulatory mechanism. We then wondered whether the mechanism is conserved at the level of the deubiquitylated lysine in Med.
Medea Lys 738 is deubiquitylated by maternal Faf during Dpp DV signaling
We examined whether the USP9X-Smad4 regulatory mechanism is conserved at the level of the deubiquitylated lysine in Med using transgenic rescue experiments that were evaluated with survival, cuticle and Hnt data. We compared the ability of a wild-type Med transgene (Med-wt) to rescue faf and Med dominant maternal enhancement of dpp hr4 with the rescuing ability of a ubiquitinresistant Med transgene. Our phylogenetic analysis showed that Lys 519 in human Smad4 (targeted by Ecto and USP9X) is conserved as Lys 738 in Med (Konikoff et al., 2008) . For the non-ubiquitylatable Med transgene, we assumed the homologous lysine was the Faf target and created Med-K738R. We used arginine as the replacement to avoid disturbing Med protein structure with a dissimilar (nonnegatively charged) amino acid. The USP9X-Smad4 model predicts that the non-ubiquitylatable transgene (Med-K738R) will be hyperactive in Dpp signaling and thus rescue dpp hr4 embryos from faf or Med maternal enhancement better than Med-wt.
We conducted the rescue experiment with two different mutants (faf F08 and Med 8 ), at two discrete levels of transgene expression and with two distinct sets of transgenes. Basal levels of expression are generated by the P transposase minimal promoter plus first intron and the K10 3ЈUTR that are present in the UASP vector (Rørth, 1998) . Overexpression is driven by nos.Gal4 (Gal4:VP16-nos.3ЈUTR, line MVD1) (van Doren et al., 1998 ) from a chromosome also containing UASP.eGFP to monitor nos.Gal4 expression. Figure S4 (supplementary material) reveals that relative levels of transgene expression in these two genotypes are essentially identical for two different transgene insertions (Med-wt and Med-K728R) in unfertilized eggs and stage 5 embryos, strongly suggesting that position effects will not interfere with this assay. Last, all balancer chromosomes were marked with transgenic lacZ to allow positive identification of experimental embryos during the Hnt analysis. Results from all rescue experiments were compared with the original, non-transgenic dpp hr4 enhancement cross. Rescue assays with faf F08 were the most informative. The logic is that loss of the deubiquitylase will be rendered less consequential in the presence of a non-ubiquitylatable and thus hyperactive Med-K738R transgene, only if Lys 738 is the ubiquitylated lysine. If any other lysine were ubiquitylated, then the loss of faf would be compensated for by Med-K738R at the same level as Med-wt. The most telling result was with the basal promoter ( Fig. 5G ; supplementary material Table S4A ). Here, expression of Med-wt increased the survival of dpp hr4 progeny 1.6-fold. By contrast, expression of Med-K738R increased the survival of dpp hr4 progeny 4.2-fold. Thus, Med-K738R performed 2.65-fold better in the rescue of dpp hr4 with basal expression. Once the transgenes were driven at ectopic levels with nos.Gal4, then Med-wt was equal to Med-K738R as both reached a rescue ceiling in this assay at roughly 80% of expected.
The survival results are supported by cuticle assays (Fig. 5A-F heterozygous embryos (Fig. 5A-F, middle and right columns) . The data validates Lys 738 as the ubiquitylation site associated with Faf modulation of Med activity.
To firmly establish the conservation of Med deubiquitylation at the level of the target lysine, we repeated the faf F08 rescue experiment with two human Smad4 UASP transgenes (Smad4-wt
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Bt5 maternal embryo from a female whose progeny survive beyond the faf-null phenotype (see Fig. 2B ) displays wildtype dpp. (C)faf
F08
/faf
BP zygotic embryo, from a cross generating cuticles with DV defects (see Fig. 1H ), displays wild-type dpp. and Smad4-K519R). The relative performance of the two Smad4 transgenes (2.14-fold better rescue with Smad4-K519R) was nearly identical to that of Med-wt versus Med-K738R at basal levels (supplementary material Fig. S5 ; Table S4B, Table S5B) .
A rescue assay with the Med 8 null allele then controlled for the possibility that Med-K738R is neomorphic. If Med acquired an unusual activity via the K738R substitution that allowed it to rescue faf F08 enhancement but this was not due to hyperactivity of normal functions, then Med-K738R should not rescue a Med loss-offunction allele. If K738R leads to hyperactivity owing to ubiquitin resistance, then it should rescue dpp hr4 embryos from Med 8 enhancement better than Med-wt. Again, the most telling result was with the basal promoter ( Fig.  5H ; supplementary material Table S4C ). Here Med-wt expression increased the survival of dpp hr4 progeny 1.6-fold. By contrast, Med-K738R expression increased the survival of dpp hr4 progeny 3.6-fold. Thus, Med-K738R performed 2.25-fold better in the rescue of dpp hr4 with basal expression. Once the transgenes were driven at ectopic levels with nos.Gal4, Med-wt again closed the gap in performance. These survival results are strongly supported by cuticle assays and Hnt data (supplementary material Fig. S6 , Table S5C ). We repeated the experiment with the Smad4 transgenes. The relative performance of the two transgenes (1.75-fold better rescue with Smad4-K519R) was only slightly lower than for Med-wt versus Med-K738R at basal levels (supplementary material Fig. S7 ; Table S4D, Table S5D ).
Overall, the rescue data indicate that Lys 738 is the key residue by which Med is regulated by the Faf deubiquitylase. These results strongly suggest that regulation of Med/Smad4 deubiquitylation by Faf/USP9X is a conserved molecular and developmental mechanism regulating TGF responsiveness. (Dupont et al., 2012) . However, USP9X activity has not yet been validated through any genetic test. Here, we provide genetic evidence that reversible ubiquitylation of Med can limit Dpp responsiveness. In faf mutants, defective deubiquitylation renders embryonic cells unable to respond appropriately to Dpp and results in defective DV patterning. This conclusion is supported by multiple observations. (1) faf mutants act as dominant maternal enhancers of dpp mutations leading to defective DV axis formation in a manner comparable with Mad and Med mutants. In addition, by reducing the levels of Dpp signaling in sog mutants, faf mutants can partially rescue DV defects caused by loss of sog, as shown for dpp mutants. (2) faf maternal mutant genotypes generate a gradient of DV defects similar to that seen in a dpp alleleic series. (3) faf mutants interact with Med mutants in a non-reciprocal manner, strongly suggesting that faf acts in the Dpp pathway by modifying Med activity. (4) Mutation of Med-K738 and human Smad4-K519 render Med and Smad4 more active then their wild-type counterparts and thus less susceptible to faf mutation -most likely as a result of resistance to the activity of a ubiquitin ligase that operates unopposed in the absence of Faf. We summarize these findings in a model depicting the role of Faf in Dpp DV signaling in Fig. 6 .
DISCUSSION
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An intriguing feature of our genetic analyses is that females heterozygous for faf BP , a complete deletion of the faf locus, do not enhance dpp hr4 , but females heterozygous for faf F08 and females homozygous for faf EP381 do. Our interpretation is that faf maternal activity must be reduced below one-half dose in the presence of one-half dose of dpp zygotic activity to generate maternal enhancement. Only homozygosity for the faf EP381 insertion and heterozygosity for the faf F08 missense mutation in the catalytic histidine reduce faf activity to that extent. Thus, faf F08 fits the criterion (phenotypic effect is more severe than a deletion) for a dominant-negative allele for faf functions in Dpp DV signaling. From this perspective, the requirement for faf is less stringent than the requirement for Mad and Med. For Mad and Med, reduction to one-half dose is sufficient to engender dominant maternal enhancement. The less stringent requirement for faf is consistent with the fact that maternally contributed Med mutations, but not faf mutations, generate synthetic lethality in double heterozygous mutant individuals.
A ubiquitylation cycle required for morphogen interpretation
The importance of a conserved zygotic extracellular system that regulates embryonic DV differentiation via the generation of a robust Dpp/BMP morphogen gradient is well known (e.g. Piccolo et al., 1996) . An equally relevant intracellular system employing ubiquitin is now being recognized that acts in parallel to control Dpp signal transduction (Xia et al., 2010) . Our data extend this recognition by showing that maternal intracellular regulation of Med activity via ubiquitylation and deubiquitylation is a fundamental feature of Dpp DV signaling.
Our study using faf mutants showed that a maternally programmed intracellular balance of Med regulative ubiquitylation and deubiquitylation is required for the zygotic extracellular system to operate and can even compensate for an excess of Dpp, as shown by the partial rescue of DV defects in sog and faf double mutants. Furthermore, faf mutations do not affect pMad activation or dorsal localization (except as a consequence of interfering with Med activity in a Dpp feedback loop). This suggests that the level of available Med (non-ubiquitylated) is a key quantitative variable, in parallel with pMad that cells employ to interpret the Dpp gradient.
These data closely mirror results obtained in mouse embryo knockouts for the Smad4 ubiquitin ligase Ecto. In this case, the absence of a Smad4-inhibitory mechanism, and thus unrestrained Smad4 activity, caused cells to respond to levels of extracellular Nodal/intracellular phospho-Smad2 that would normally be too small to activate gene expression. Thus, a global picture emerges whereby cells keep Smad4 constantly in check, and that this is essential for their ability to sense quantitative differences in R-Smad activity.
However, one wonders why do cells need such a cycle, instead of simply fine-tuning Smad4 expression levels? One interesting possibility is that Smad4 monoubiquitylation, which is promoted by TGF signals in mammalian cells, might serve to continuously clear active Smad complexes from promoters. This hypothesis is supported by recent findings indicating that Ecto is recruited to TGF target promoters in a Smad4-dependent fashion and that the enzymatic activity of Ecto on Smad4 is promoted when Ecto is bound to chromatin (Agricola et al., 2011) . In this respect, Smad4
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Development 139 (15) ubiquitylation favors a dynamic state for R-Smads, keeping them exposed to fluctuations in extracellular concentrations of TGF ligands (Schmierer and Hill, 2007) . The Smad4 ubiquitin cycling model implies the existence of a ubiquitin ligase for Med. One candidate is Bonus, the Drosophila protein most closely related to the three vertebrate Tif1 proteins (Beckstead et al., 2001) . A second is Highwire, a ligase for Med at the neuromuscular junction (McCabe et al., 2004) . dSmurf, a ligase shown to affect Mad but not Med in Dpp DV signaling, is not a candidate (Liang et al., 2003) . We tested bonus and highwire mutants for DV phenotypes and found they are inconsistent with those predicted for a Med ubiquitin ligase. Additional candidates are currently under investigation.
In summary, our study reveals that Med deubiquitylation by Faf is a conserved mechanism required for proper interpretation of the Dpp morphogen gradient and embryonic DV axis formation.
